-
公开(公告)号：US20120070495A1
公开(公告)日：2012-03-22
申请号：US13045108
申请日：2011-03-10
申请人： Syed M. SHAH , Christopher Richard DIORIO , Eric C. EHRNSPERGER , Xu MENG , Kadum A. AL SHAREFFI , Jonathan Marc COHEN
发明人： Syed M. SHAH , Christopher Richard DIORIO , Eric C. EHRNSPERGER , Xu MENG , Kadum A. AL SHAREFFI , Jonathan Marc COHEN
IPC分类号： A61K31/485 , B02C23/18 , A61P25/04 , C07D489/08 , A61K9/28
CPC分类号： A61K31/485 , A61K9/0053 , A61K9/2009 , A61K9/2013 , A61K9/2054 , A61K9/2077 , A61K9/28 , A61K47/12 , A61K47/20 , C07D489/08
摘要： The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
摘要翻译： 本发明提供了包含甲基纳曲酮或其盐的组合物及其组合物和制剂，用于口服给药。
-
2.发明申请O-DESMETHYLVENLAFAXINE AND BAZEDOXIFENE COMBINATION PRODUCT AND USES THEREOF 审中-公开O-二甲氧基二苯醚和巴西昔康组合产品及其用途公开(公告)号：US20100221445A1
公开(公告)日：2010-09-02
申请号：US12771350
申请日：2010-04-30
CPC分类号： C07C215/64 , A61K9/146 , A61K9/1652 , A61K9/209 , A61K9/5047 , A61K9/5084 , A61K31/137 , A61K31/205 , A61K31/55 , A61K45/06 , C07D209/12 , C07D403/12 , A61K2300/00
摘要： A combination product containing at least two active compounds, O-desmethylvenlafaxine or a pharmaceutically acceptable salt thereof and bazedoxifene or a pharmaceutically acceptable salt thereof is described. Also described are methods of making and using this combination product to treat a variety of conditions associated with low circulating estrogen levels or low estrogen receptor activity.
摘要翻译： 描述了含有至少两种活性化合物O-去甲基文拉法新或其药学上可接受的盐和巴西多昔芬或其药学上可接受的盐的组合产品。 还描述了制备和使用该组合产品以治疗与低循环雌激素水平或低雌激素受体活性相关的各种病症的方法。
-
公开(公告)号：US20070259041A1
公开(公告)日：2007-11-08
申请号：US11799870
申请日：2007-05-03
IPC分类号： A61K31/137 , A61K9/24
CPC分类号： A61K31/277 , A61K9/2054 , A61K9/2846 , A61K9/2866 , A61K31/137
摘要： Solid dosage formulations are provided for a compound having the formula: wherein R2 is Cl, F, Br, CH3, CF3, SCH3, NHCH3, NO2, CN, OH, OC1—C6 alkyl, or substituted OC1—C6 alkyl, or a prodrug or a pharmaceutically acceptable salt thereof. Formulations for tablets and multiparticulates containing a compound according to the above formula, a rate controlling component, and a binder are described, including formulations containing a seal coating, release rate controlling coating, and/or enteric coating. Pharmaceutical uses and kits thereof are also described.
摘要翻译： 提供了具有下式的化合物的固体剂型：其中R 2是Cl，F，Br，CH 3，CF 3，SCH NH 3，NH 2，NO 2，CN，OH，OC 1 -C 6， 或其取代的OC 1 -C 6烷基，或其前药或药学上可接受的盐。 描述了包含根据上式的化合物，速率控制组分和粘合剂的片剂和多颗粒的制剂，包括含有密封涂层，释放速率控制涂层和/或肠溶衣的制剂。 还描述了药物用途及其试剂盒。
-
公开(公告)号：US08524281B2
公开(公告)日：2013-09-03
申请号：US12940797
申请日：2010-11-05
申请人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene James Murphy
发明人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene James Murphy
IPC分类号： A61K31/4709 , A61K35/00
CPC分类号： A61K9/5073 , A61K9/5026 , A61K31/4709
摘要： The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors.
-
公开(公告)号：US08524276B2
公开(公告)日：2013-09-03
申请号：US13045108
申请日：2011-03-10
申请人： Syed M. Shah , Christopher Richard Diorio , Eric C. Ehrnsperger , Xu Meng , Kadum A. Al Shareffi , Jonathan Marc Cohen
发明人： Syed M. Shah , Christopher Richard Diorio , Eric C. Ehrnsperger , Xu Meng , Kadum A. Al Shareffi , Jonathan Marc Cohen
IPC分类号： A61K9/20
CPC分类号： A61K31/485 , A61K9/0053 , A61K9/2009 , A61K9/2013 , A61K9/2054 , A61K9/2077 , A61K9/28 , A61K47/12 , A61K47/20 , C07D489/08
摘要： The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration.
摘要翻译： 本发明提供了包含甲基纳曲酮或其盐的组合物及其组合物和制剂，用于口服给药。
-
6.发明申请COATED DRUG SPHEROIDS AND USES THEREOF FOR ELIMINATING OR REDUCING CONDITIONS SUCH AS EMESIS AND DIARRHEA 有权涂层药物及其用于消除或减少诸如EMESIS和DIARRHEA等条件的用途公开(公告)号：US20110165257A1
公开(公告)日：2011-07-07
申请号：US12940797
申请日：2010-11-05
申请人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene Murphy
发明人： Sripriya Venkata Ramana Rao , Syed Muzafar Shah , Christopher Richard Diorio , Maja Vencl-Joncic , Eugene Murphy
IPC分类号： A61K31/4709 , A61K9/14 , A61P35/00
CPC分类号： A61K9/5073 , A61K9/5026 , A61K31/4709
摘要： The present invention provides an oral pharmaceutical formulation comprising coated spheroids of a kinase inhibitor such as neratinib, which formulation is designed to reduce or eliminate side effects associated with existing oral formulations of kinase inhibitors.
摘要翻译： 本发明提供了包含激酶抑制剂例如那赫那定的包被球体的口服药物制剂，该制剂设计用于减少或消除与现有的激酶抑制剂的口服制剂相关的副作用。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.016 秒)
